Research Progress of Progesterone Preparations: a mini Review.

CONCLUSION: Although progesterone has first-pass effects, with these methods, the bioavailability and compliance can greatly increase. PMID: 29708071 [PubMed - as supplied by publisher]
Source: Current Drug Metabolism - Category: Drugs & Pharmacology Authors: Tags: Curr Drug Metab Source Type: research

Related Links:

A drug used in hormone replacement therapy can target estrogen receptors that have become resistant to breast cancer treatments.
Source: eLife - Category: Biomedical Science Tags: Cancer Biology Source Type: research
This article is protected by copyright. All rights reserved.
Source: The Obstetrician and Gynaecologist - Category: OBGYN Authors: Tags: Reviews Source Type: research
(CNN) — UK scientists have developed an online calculator that could enable doctors to more accurately predict a patient’s chance of developing breast cancer. If rolled out, the new tool could change the way in which the condition is treated. Among other things, details of family history, genetics, weight, alcohol consumption, age at menopause and use of hormone replacement therapy will all be considered by doctors when assessing a woman’s risk of developing breast cancer — the most common form of cancer in the UK. Each of these factors has “a small impact on the likelihood of developing the d...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Breast Cancer CNN Local TV Source Type: news
ConclusionRates of mammography use over time do not necessarily reflect national guideline releases or establishment of organized screening programs.
Source: Cancer Causes and Control - Category: Cancer & Oncology Source Type: research
Source: BMJ Comments - Category: General Medicine Source Type: forums
WOMEN who take hormone replacement therapy tablets are at a higher risk of developing potentially deadly blood clots, a study revealed yesterday.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
THURSDAY, Jan. 10, 2019 -- Oral hormone replacement therapy (HRT) is associated with an increased risk for venous thromboembolism (VTE), while transdermal preparations are not linked to increased risk, according to a study published online Jan. 9 in...
Source: - Pharma News - Category: Pharmaceuticals Source Type: news
Most oral preparations of hormone replacement therapy (HRT) are associated with a higher risk of venous thromboembolism (VTE), a study published in The BMJ has found.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
Source: BMJ - Category: General Medicine Source Type: research
Abstract Nowadays, postmenopausal women are largely undertreated. Analysis of conflicting results among different studies suggests that hormone replacement therapy (HRT) can prevent osteoporosis and cardiovascular disease in symptomatic, early postmenopausal women. In fact, climacteric symptoms are related to an increased risk of chronic conditions, including hypertension and cardiovascular disease. Different scientific societies have pointed out that patient selection, timing of initiation, and the choice of the type and dose of HRT used are the major determinants of the ultimate effect of HRT on women's health a...
Source: Climacteric - Category: Geriatrics Authors: Tags: Climacteric Source Type: research
More News: Drugs & Pharmacology | Hormone Replacement Therapy | Hormones | Study